|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
35,410,000 |
Market
Cap: |
14.28(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$180.52 - $413.31 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 463 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Medpace Holdings is a holding company. Through its subsidiaries, Co. is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Co. provides a suite of services supporting the clinical development process from Phase I to Phase IV across a range of therapeutic areas. Co.'s services include medical department, clinical trial management, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, regulatory affairs, medical writing, biometrics and data sciences, pharmacovigilance, and quality assurance.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
2,000,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$309,116,534 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
34 |
Total Shares Sold |
1,742,072 |
2,404,472 |
3,583,248 |
3,608,378 |
Total Sell Value |
$699,894,249 |
$883,563,199 |
$1,169,841,547 |
$1,175,475,107 |
Total People Sold |
6 |
6 |
8 |
8 |
Total Sell Transactions |
39 |
65 |
84 |
89 |
End Date |
2023-12-28 |
2023-09-26 |
2023-03-28 |
2022-03-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Brady Kevin M. |
CFO & Treasurer |
|
2022-11-16 |
4 |
S |
$227.09 |
$78,119 |
D/D |
(344) |
3,000 |
|
19% |
|
Brady Kevin M. |
CFO & Treasurer |
|
2022-11-15 |
4 |
S |
$229.30 |
$379,721 |
D/D |
(1,656) |
3,344 |
|
19% |
|
Geiger Jesse J |
President |
|
2022-11-15 |
4 |
S |
$230.00 |
$1,610,000 |
D/D |
(7,000) |
6,382 |
|
19% |
|
Geiger Jesse J |
President |
|
2022-11-15 |
4 |
OE |
$28.32 |
$198,240 |
D/D |
7,000 |
13,382 |
|
- |
|
Kraft Robert O. |
Director |
|
2022-11-01 |
4 |
S |
$221.42 |
$2,132,275 |
D/D |
(9,630) |
0 |
|
20% |
|
Kraft Robert O. |
Director |
|
2022-11-01 |
4 |
OE |
$23.00 |
$221,490 |
D/D |
9,630 |
9,630 |
|
- |
|
Ewald Stephen P |
General Counsel & Corp. Secy. |
|
2022-10-27 |
4 |
S |
$220.53 |
$1,433,445 |
D/D |
(6,500) |
14,854 |
|
19% |
|
Ewald Stephen P |
General Counsel & Corp. Secy. |
|
2022-10-27 |
4 |
OE |
$32.05 |
$208,325 |
D/D |
6,500 |
21,354 |
|
- |
|
Troendle August J. |
CEO |
|
2022-09-22 |
4 |
AB |
$154.59 |
$8,877,485 |
I/I |
57,426 |
6,483,019 |
|
52% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-09-22 |
4 |
AB |
$154.59 |
$8,877,485 |
D/D |
57,426 |
6,483,019 |
|
52% |
|
Troendle August J. |
CEO |
|
2022-09-21 |
4 |
AB |
$161.63 |
$15,212,454 |
I/I |
94,119 |
6,425,593 |
|
53% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-09-21 |
4 |
AB |
$161.63 |
$15,212,454 |
D/D |
94,119 |
6,425,593 |
|
53% |
|
Troendle August J. |
CEO |
|
2022-09-20 |
4 |
AB |
$155.14 |
$14,601,622 |
I/I |
94,119 |
6,331,474 |
|
46% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-09-20 |
4 |
AB |
$155.14 |
$14,601,622 |
D/D |
94,119 |
6,331,474 |
|
46% |
|
Troendle August J. |
CEO |
|
2022-09-19 |
4 |
AB |
$153.48 |
$14,445,384 |
I/I |
94,119 |
6,237,355 |
|
43% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-09-19 |
4 |
AB |
$153.48 |
$14,445,384 |
D/D |
94,119 |
6,237,355 |
|
43% |
|
Troendle August J. |
CEO |
|
2022-09-16 |
4 |
AB |
$149.58 |
$9,351,143 |
I/I |
62,516 |
6,143,236 |
|
42% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-09-16 |
4 |
AB |
$149.58 |
$9,351,143 |
D/D |
62,516 |
6,143,236 |
|
42% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-09-15 |
4 |
AB |
$153.11 |
$9,571,825 |
D/D |
62,516 |
6,080,720 |
|
48% |
|
Troendle August J. |
CEO |
|
2022-09-15 |
4 |
AB |
$153.11 |
$9,571,825 |
I/I |
62,516 |
6,080,720 |
|
48% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-09-14 |
4 |
AB |
$152.66 |
$9,543,693 |
D/D |
62,516 |
6,018,204 |
|
52% |
|
Troendle August J. |
CEO |
|
2022-09-14 |
4 |
AB |
$152.66 |
$9,543,693 |
I/I |
62,516 |
6,018,204 |
|
52% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-09-13 |
4 |
AB |
$157.12 |
$9,822,514 |
D/D |
62,516 |
5,955,688 |
|
49% |
|
Troendle August J. |
CEO |
|
2022-09-13 |
4 |
AB |
$157.12 |
$9,822,514 |
I/I |
62,516 |
5,955,688 |
|
49% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-09-12 |
4 |
AB |
$167.58 |
$10,476,264 |
D/D |
62,515 |
5,893,172 |
|
39% |
|
215 Records found
|
|
Page 1 of 9 |
|
|